Pediatric Vaccination

Myocarditis FDA Policies Spikevax Moderna Vaccine mRNA-1273 (Spikevax)

FDA Grants Full Approval to Moderna’s Pediatric COVID-19 Vaccine for At-Risk Children

Full licensure of Moderna’s Spikevax for at-risk children underscores federal policy narrowing pediatric COVID-19 vaccination during ongoing legal challenges.

4 ARTICLES

2mo ago

HHS Secretary RFK Jr. Weighs Removing COVID-19 Vaccine From Childhood Schedule